Molecular regulation of protective CD8 immunity against influenza infection
Molecular regulation of protective CD8 immunity against influenza infection
批准号:
10613483
负责人:
Jie Sun
金额:
$49.66万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
未结题
起止时间:
2015-02-10 至 2025-04-30
关键词:
AdultCD8-Positive T-LymphocytesCD8B1 geneCellsChildCuesDataDevelopmentEpigenetic ProcessFundingFutureGADD45BGene Expression ProfilingGenerationsGenetic TranscriptionGoalsGrantHealthHumanImmunityImmunologic MemoryInfluenzaInfluenza TherapeuticInfluenza vaccinationInterventionLower Respiratory Tract InfectionLungMAP3K7 geneMaintenanceMediatingMemoryMetabolicMetabolic ControlMitochondriaMolecularMolecular TargetPathway interactionsPersonsPlayPreventionProbabilityReceptor SignalingRegulationReportingResearchRespiratory SystemRoleSignal PathwaySignal TransductionT cell responseT memory cellT-Cell DevelopmentT-LymphocyteTissuesTranscriptional RegulationTransforming Growth Factor betaTransforming Growth Factor beta ReceptorsTransgenic MiceUpper Respiratory InfectionsVaccinesanti-influenzacross reactivitycytokinecytotoxic CD8 T cellsdesignepigenetic profilingfitnessfuture pandemicglobal healthinducible Creinfluenza infectioninfluenza virus vaccineinfluenzavirusmitochondrial fitnessmitochondrial metabolismmouse modelnovelpandemic influenzapathogentherapeutic vaccinetissue resident memory T celltranscription factor
中文摘要
摘要/摘要
驻留在非淋巴组织中的组织驻留记忆T细胞(TRM)提供了优越的免疫力
对包括流感病毒感染在内的各种病原体与循环记忆T的比较
细胞。
目前,
调控CD8 TRM编程、维持的分子和代谢机制
组织中的功能还没有完全被理解。揭开肺的新机制
流感感染后保护性TRM反应被调节可能有助于未来流感的设计
治疗学和/或流感疫苗。这笔拨款的长期目标是研究分子
呼吸道保护性CD8 T细胞免疫发展的调控机制
流感感染。
我们最近发现了转录因子Bhlhe40,它在调节适应性方面起着核心作用
和流感特异性CD8TRM的功能。在这个应用中,我们假设非规范的TGFbR
信号通过TAK1/Gadd45b依赖的途径促进Bhlhe40的表达和TRM
线粒体健康,从而促进TRM对流感的维持和保护功能
感染。提出了三个具体目标:目标1:确定
Bhlhe40促进流感感染后的保护性TRM反应。目标2:阐明基因的作用
TAK1-Gadd45b途径介导的非典型TGFBR信号在调节TRM发育中的作用
和/或维护。目的3:明确TAK1-Gadd45b-Gadd45b调节线粒体适合性的作用。
Bhlhe40途径,在调节TRM反应和保护功能中发挥作用。
每年,流感病毒感染5%-10%的成年人和20%-30%的儿童,导致多达50万人死亡
全球各地的人。了解调节形成和/或的细胞和分子机制
在流感感染和/或免疫后维持肺保护性TRM反应可能有助于
未来流感疗法和新型流感疫苗的设计。
英文摘要
Summary/Abstract
Tissue-resident memory T cells (TRM) that reside within the non-lymphoid tissues provide superior immunity
against a variety of pathogens including influenza virus infection compared to the circulating memory T
cells.
Currently,
the molecular and metabolic mechanisms regulating CD8 TRM programming, maintenance
and functions in the tissue are incompletely understood. Unravelling novel mechanisms by which lung
protective TRM responses are regulated following influenza infection may aid the design of future influenza
therapeutics and/or influenza vaccines. The long-term objective of this grant is to investigate the molecular
mechanisms regulating the development of protective CD8 T cell immunity in the respiratory tract during
influenza infection.
We recently have identified the transcription factor, Bhlhe40, plays a central role in regulating the fitness
and function of influenza-specific CD8 TRM. In this application, we hypothesize that non-canonical TGFbR
signaling, through TAK1/Gadd45b-dependent pathway, facilitates Bhlhe40 expression and TRM
mitochondrial health, thereby promoting the maintenance and protective functions of TRM against influenza
infection. Three specific Aims are proposed: Aim 1: To determine the underlying mechanisms by which
Bhlhe40 promotes protective TRM responses following influenza infection. Aim 2: To elucidate the roles of
non-canonical TGFBR signaling, mediated through TAK1-Gadd45b pathway, in regulating TRM development
and/or maintenance. Aim 3: To define the roles of mitochondrial fitness, modulated by TAK1-Gadd45b-
Bhlhe40 pathway, in regulating TRM responses and protective function.
Each year, influenza virus infects 5–10% of adults and 20–30% of children, killing as many as 500,000
people globally. Understanding the cellular and molecular mechanisms regulating the formation and/or
maintenance of lung protective TRM responses following influenza infection and/or immunization may aid the
design of future influenza therapeutics and novel influenza vaccines.
期刊论文(15)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1172/jci.insight.150999
发表时间:
2021-11-22
期刊:
JCI insight
影响因子:
8
作者:
[Berti A, Hillion S, Hummel AM, Son YM, Chriti N, Peikert T, Carmona EM, Abdulahad WH, Heeringa P, Harris KM, St Clair EW, Brunetta P, Fervenza FC, Langford CA, Kallenberg CG, Merkel PA, Monach PA, Seo P, Spiera RF, Stone JH, Grandi G, Sun J, Pers JO, Specks U, Cornec D, RAVE-ITN Research Group]
通讯作者:
RAVE-ITN Research Group
DOI:
10.3390/cancers10110403
发表时间:
2018-10-26
期刊:
Cancers
影响因子:
5.2
作者:
[Gu D, Lin H, Zhang X, Fan Q, Chen S, Shahda S, Liu Y, Sun J, Xie J]
通讯作者:
Xie J
DOI:
10.1002/eji.201747034
发表时间:
2017-07
期刊:
European journal of immunology
影响因子:
5.4
作者:
[Xie MM, Koh BH, Hollister K, Wu H, Sun J, Kaplan MH, Dent AL]
通讯作者:
Dent AL
Rag-GTPase-TFEB/TFE3 axis controls B cell mitochondrial fitness and humoral immunity independent of mTORC1.
Rag-GTPase-TFEB/TFE3 轴独立于 mTORC1 控制 B 细胞线粒体适应性和体液免疫。
DOI:
10.21203/rs.3.rs-3957355/v1
发表时间:
2024
期刊:
Research square
影响因子:
--
作者:
[Zhu,Xingxing, Wu,Yue, Li,Yanfeng, Zhou,Xian, Watzlawik,JensO, Chen,YinMaggie, Raybuck,ArielL, Billadeau,Daniel, Shapiro,Virginia, Springer,Wolfdieter, Sun,Jie, Boothby,MarkR, Zeng,Hu]
通讯作者:
Zeng,Hu
Uncover mechanisms underlying the development of chronic lung sequelae post COVID-19
-
批准号:10734747
-
项目类别:
-
资助金额:$72.03万
-
财政年份:2023
-
负责人:Jie Sun
-
依托单位:
Determinants of Convalescent and Vaccine-induced Mucosal Specific Immunity to SARS-CoV-2 and Variants of Concern in Children with Asthma
-
批准号:10638521
-
项目类别:
-
资助金额:$70.72万
-
财政年份:2023
-
负责人:Jie Sun
-
依托单位:
Modeling severe respiratory syncytial virus pathogenesis in bronchopulmonarydysplasia
-
批准号:10515456
-
项目类别:
-
资助金额:$19.88万
-
财政年份:2022
-
负责人:Jie Sun
-
依托单位:
Roles of tissue-resident helper T cells in mucosal immunity against influenzainfection
-
批准号:10605297
-
项目类别:
-
资助金额:$61.31万
-
财政年份:2022
-
负责人:Jie Sun
-
依托单位:
Roles of tissue-resident helper T cells in mucosal immunity against influenzainfection
-
批准号:10393621
-
项目类别:
-
资助金额:$61.69万
-
财政年份:2022
-
负责人:Jie Sun
-
依托单位:
Roles of tissue-resident helper T cells in mucosal immunity against influenzainfection
-
批准号:10515543
-
项目类别:
-
资助金额:$51.32万
-
财政年份:2022
-
负责人:Jie Sun
-
依托单位:
COVID-19 competitive revision: BALANCING PROTECTIVE IMMUNITY AND CHRONIC SEQUELAE BY RESIDENT CD8 T CELLS
-
批准号:10224990
-
项目类别:
-
资助金额:$21.16万
-
财政年份:2020
-
负责人:Jie Sun
-
依托单位:
Modeling severe respiratory syncytial virus pathogenesis in bronchopulmonary dysplasia
-
批准号:9981352
-
项目类别:
-
资助金额:$23.85万
-
财政年份:2020
-
负责人:Jie Sun
-
依托单位:
Elucidating the roles of alveolar macrophage inflammation and self renewal duringinfluenza infection
-
批准号:10515526
-
项目类别:
-
资助金额:$27.07万
-
财政年份:2020
-
负责人:Jie Sun
-
依托单位:
Balancing protective immunity and chronic sequelae by resident CD8 T cells
-
批准号:9981307
-
项目类别:
-
资助金额:$56.5万
-
财政年份:2020
-
负责人:Jie Sun
-
依托单位:
Elucidating the roles of alveolar macrophage inflammation and self renewal duringinfluenza infection
-
批准号:10652322
-
项目类别:
-
资助金额:$45.17万
-
财政年份:2020
-
负责人:Jie Sun
-
依托单位:
Mechanisms of influenza viral pathogenesis in normal hosts and hosts with chronic diseases
-
批准号:10198309
-
项目类别:
-
资助金额:$49.41万
-
财政年份:2020
-
负责人:Jie Sun
-
依托单位:
Balancing protective immunity and chronic sequelae by resident CD8 T cells
-
批准号:10265754
-
项目类别:
-
资助金额:$40.61万
-
财政年份:2020
-
负责人:Jie Sun
-
依托单位:
Elucidating the roles of alveolar macrophage inflammation and selfrenewal during influenza infection
-
批准号:10063352
-
项目类别:
-
资助金额:$45.6万
-
财政年份:2020
-
负责人:Jie Sun
-
依托单位:
Roles of tissue-resident helper T cells in mucosal immunity against influenza infection
-
批准号:10065060
-
项目类别:
-
资助金额:$51.5万
-
财政年份:2020
-
负责人:Jie Sun
-
依托单位:
Balancing protective immunity and chronic sequelae by resident CD8 T cells
-
批准号:10515461
-
项目类别:
-
资助金额:$56.97万
-
财政年份:2020
-
负责人:Jie Sun
-
依托单位:
Elucidating the roles of alveolar macrophage inflammation and self renewal duringinfluenza infection
-
批准号:10425391
-
项目类别:
-
资助金额:$46.32万
-
财政年份:2020
-
负责人:Jie Sun
-
依托单位:
Balancing protective immunity and chronic sequelae by resident CD8 T cells
-
批准号:10549833
-
项目类别:
-
资助金额:$56.97万
-
财政年份:2020
-
负责人:Jie Sun
-
依托单位:
Simultaneously boosting both humoral and cellular immunity following vaccination
-
批准号:9401954
-
项目类别:
-
资助金额:$31.98万
-
财政年份:2017
-
负责人:Jie Sun
-
依托单位:
Molecular regulation of protective CD8 immunity against influenza infection
-
批准号:10161713
-
项目类别:
-
资助金额:$3.43万
-
财政年份:2015
-
负责人:Jie Sun
-
依托单位:
海外基金